• Citer

PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade: Data from a Belgian multicentric study of 546 patients

par Oosterlinck, W;Mattelaer, J;Casselman, Jan W.;Van Velthoven, Roland ;Derde, Marie Paule;Kaufman, L.
Référence Acta urologica Belgica, 65, 3, page (63-71)
Publication Publié, 1997-10

Article révisé par les pairs

• Détails
• Contenu

Résumé :

To study the prognostic value of the prostate-specific antigen (PSA) response and its relationship with other initial prognostic factors during the treatment of advanced prostatic carcinoma with total androgen blockade.